4//SEC Filing
Myszkowski Kenneth Allen 4
Accession 0001209191-21-003295
CIK 0000879407other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:06 PM ET
Size
7.0 KB
Accession
0001209191-21-003295
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2021-01-11$81.02/sh−11,597$939,589→ 445,446 total - Sale
Common Stock
2021-01-12$81.00/sh−1,441$116,721→ 444,005 total
Footnotes (1)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.08, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001486672
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:06 PM ET
- Size
- 7.0 KB